nach oben

Digestive Diseases and Sciences

Erschienen in:

06.02.2021 | Original Article

Use of Artificial Intelligence in the Prediction of Malignant Potential of Gastric Gastrointestinal Stromal Tumors

verfasst von: Gulseren Seven, Gokhan Silahtaroglu, Koray Kochan, Ali Tuzun Ince, Dilek Sema Arici, Hakan Senturk

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

This study aimed to investigate whether AI via a deep learning algorithm using endoscopic ultrasonography (EUS) images could predict the malignant potential of gastric gastrointestinal stromal tumors (GISTs).

Methods

A series of patients who underwent EUS before surgical resection for gastric GISTs were included. A total of 685 images of GISTs from 55 retrospectively included patients were used as the training data set for the AI system. Convolutional neural networks were constructed to build a deep learning model. After applying the synthetic minority oversampling technique, 70% of the generated images were used for AI training and 30% were used to test AI diagnoses. Next, validation was performed using 153 EUS images of 15 patients with GISTs. In addition, conventional EUS features of 55 patients in the training cohort were evaluated to predict the malignant potential of GISTs and mitotic index.

Results

The overall sensitivity, specificity, and accuracy of the AI system for predicting malignancy risk were 83%, 94%, and 82% in the training dataset, and 75%, 73%, and 66% in the validation cohort, respectively. When patients were divided into low-risk and high-risk groups, sensitivity, specificity, and accuracy increased to 99% in the training dataset and 99.7%, 99.7%, and 99.6%, respectively, in the validation cohort. No conventional EUS features were found to be associated with either malignant potential or mitotic index (P > 0.05).

Conclusions

AI via a deep learning algorithm using EUS images could predict the malignant potential of gastric GISTs with high accuracy.

Graphic Abstract

Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52–68. https://doi.org/10.1097/01.pas.0000146010.92933.de.CrossRefPubMed

Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol 2016;40:39–46. https://doi.org/10.1016/j.canep.2015.10.031.CrossRefPubMed

Baysal B, Masri OA, Eloubeidi MA, Senturk H. The role of EUS and EUS-guided FNA in the management of subepithelial lesions of the esophagus: a large, single-center experience. Endosc Ultrasound 2017;6:308–316. https://doi.org/10.4103/2303-9027.155772.CrossRefPubMedPubMedCentral

Chandrasekhara V, Ginsberg GG. Endoscopic management of gastrointestinal stromal tumors. Curr Gastroenterol Rep 2011;13:532–539. https://doi.org/10.1007/s11894-011-0224-6.CrossRefPubMed

Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459–465. https://doi.org/10.1053/hupa.2002.123545.CrossRefPubMed

Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70–83. https://doi.org/10.1053/j.semdp.2006.09.001.CrossRefPubMed

Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008;39:1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025.CrossRefPubMed

Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477–489. https://doi.org/10.1097/00000478-200604000-00008.CrossRefPubMed

Larghi A, Fuccio L, Chiarello G, Attili F, Vanella G, Paliani GB et al. Fine-needle tissue acquisition from subepithelial lesions using a forward-viewing linear echoendoscope. Endoscopy 2014;46:39–45. https://doi.org/10.1055/s-0033-1344895.CrossRefPubMed

10.

Polkowski M, Gerke W, Jarosz D, Nasierowska-Guttmejer A, Rutkowski P, Nowecki ZI et al. Diagnostic yield and safety of endoscopic ultrasound-guided trucut [corrected] biopsy in patients with gastric submucosal tumors: a prospective study. Endoscopy 2009;41:329–334. https://doi.org/10.1055/s-0029-1214447.CrossRefPubMed

11.

Ricci R, Chiarello G, Attili F, Fuccio L, Alfieri S, Persiani R et al. Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours. Dig Liver Dis 2015;47:291–295. https://doi.org/10.1016/j.dld.2014.12.011.CrossRefPubMed

12.

Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002;55:37–43. https://doi.org/10.1067/mge.2002.120323.CrossRefPubMed

13.

Okubo K, Yamao K, Nakamura T, Tajika M, Sawaki A, Hara K et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach. J Gastroenterol 2004;39:747–753. https://doi.org/10.1007/s00535-004-1383-0.CrossRefPubMed

14.

Seven G, Kochan K, Caglar E, Kiremitci S, Koker IH, Senturk H. Evaluation of Ki67 index in endoscopic ultrasound-guided fine needle aspiration samples for the assessment of malignancy risk in gastric gastrointestinal stromal tumors. Dig Dis. 2020. https://doi.org/10.1159/000511994.CrossRefPubMed

15.

Cağlar E, Hatemi I, Atasoy D, Sişman G, Sentürk H. Concordance of endoscopic ultrasonography-guided fine needle aspiration diagnosis with the final diagnosis in subepithelial lesions. Clin Endosc 2013;46:379–383. https://doi.org/10.5946/ce.2013.46.4.379.CrossRefPubMedPubMedCentral

16.

Wani S, Muthusamy VR, Komanduri S. EUS-guided tissue acquisition: an evidence-based approach (with videos). Gastrointest Endosc 2014;80:939–59.e7. https://doi.org/10.1016/j.gie.2014.07.066.CrossRefPubMed

17.

Jeon SW, Park YD, Chung YJ, Cho CM, Tak WY, Kweon YO et al. Gastrointestinal stromal tumors of the stomach: endosonographic differentiation in relation to histological risk. J Gastroenterol Hepatol 2007;22:2069–2075. https://doi.org/10.1111/j.1440-1746.2006.04767.x.CrossRefPubMed

18.

Shah P, Gao F, Edmundowicz SA, Azar RR, Early DS. Predicting malignant potential of gastrointestinal stromal tumors using endoscopic ultrasound. Dig Dis Sci 2009;54:1265–1269. https://doi.org/10.1007/s10620-008-0484-7.CrossRefPubMed

19.

Chen TH, Hsu CM, Chu YY, Wu CH, Chen TC, Hsu JT et al. Association of endoscopic ultrasonographic parameters and gastrointestinal stromal tumors (GISTs): can endoscopic ultrasonography be used to screen gastric GISTs for potential malignancy? Scand J Gastroenterol 2016;51:374–377. https://doi.org/10.3109/00365521.2015.1095350.CrossRefPubMed

20.

Chen T, Xu L, Dong X, Li Y, Yu J, Xiong W et al. The roles of CT and EUS in the preoperative evaluation of gastric gastrointestinal stromal tumors larger than 2 cm. Eur Radiol 2019;29:2481–2489. https://doi.org/10.1007/s00330-018-5945-6.CrossRefPubMed

21.

Brand B, Oesterhelweg L, Binmoeller KF, Sriram PV, Bohnacker S, Seewald S et al. Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. Dig Liver Dis 2002;34:290–297. https://doi.org/10.1016/s1590-8658(02)80150-5.CrossRefPubMed

22.

Chak A, Canto MI, Rösch T, Dittler HJ, Hawes RH, Tio TL et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997;45:468–473. https://doi.org/10.1016/s0016-5107(97)70175-5.CrossRefPubMed

23.

Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Smaïl-Tabbone M et al. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology 2020;158:76-94.e2. https://doi.org/10.1053/j.gastro.2019.08.058.CrossRefPubMed

24.

Kuwahara T, Hara K, Mizuno N, Okuno N, Matsumoto S, Obata M et al. Usefulness of deep learning analysis for the diagnosis of malignancy in intraductal papillary mucinous neoplasms of the pancreas. Clin Transl Gastroenterol 2019;10:1–8. https://doi.org/10.14309/ctg.0000000000000045.CrossRefPubMed

25.

Kurita Y, Kuwahara T, Hara K, Mizuno N, Okuno N, Matsumoto S et al. Diagnostic ability of artificial intelligence using deep learning analysis of cyst fluid in differentiating malignant from benign pancreatic cystic lesions. Sci Rep 2019;9:6893. https://doi.org/10.1038/s41598-019-43314-3.CrossRefPubMedPubMedCentral

26.

Maeda Y, Kudo SE, Mori Y, Misawa M, Ogata N, Sasanuma S et al. Fully automated diagnostic system with artificial intelligence using endocytoscopy to identify the presence of histologic inflammation associated with ulcerative colitis (with video). Gastrointest Endosc 2019;89:408–415. https://doi.org/10.1016/j.gie.2018.09.024.CrossRefPubMed

27.

Horie Y, Yoshio T, Aoyama K, Yoshimizu S, Horiuchi Y, Ishiyama A et al. Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks. Gastrointest Endosc 2019;89:25–32. https://doi.org/10.1016/j.gie.2018.07.037.CrossRefPubMed

28.

Zhu Y, Wang QC, Xu MD, Zhang Z, Cheng J, Zhong YS et al. Application of convolutional neural network in the diagnosis of the invasion depth of gastric cancer based on conventional endoscopy. Gastrointest Endosc 2019;89:806–15.e1. https://doi.org/10.1016/j.gie.2018.11.011.CrossRefPubMed

29.

Goodfellow I. Deep learning. Cambridge: MIT Press; 2016.

30.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 2018;16:536–563. https://doi.org/10.6004/jnccn.2018.0025.CrossRef

31.

Joo MK, Park JJ, Kim H, Koh JS, Lee BJ, Chun HJ et al. Endoscopic versus surgical resection of GI stromal tumors in the upper GI tract. Gastrointest Endosc 2016;83:318–326. https://doi.org/10.1016/j.gie.2015.07.034.CrossRefPubMed

32.

Kim GH, Choi KD, Gong CS, Lee IS, Park YS, Han M et al. Comparison of the treatment outcomes of endoscopic and surgical resection of GI stromal tumors in the stomach: a propensity score-matched case–control study. Gastrointest Endosc 2020;91:527–536. https://doi.org/10.1016/j.gie.2019.10.020.CrossRefPubMed

Titel: Use of Artificial Intelligence in the Prediction of Malignant Potential of Gastric Gastrointestinal Stromal Tumors
verfasst von: Gulseren Seven
Gokhan Silahtaroglu
Koray Kochan
Ali Tuzun Ince
Dilek Sema Arici
Hakan Senturk
Publikationsdatum: 06.02.2021
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 1/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-021-06830-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Use of Artificial Intelligence in the Prediction of Malignant Potential of Gastric Gastrointestinal Stromal Tumors